| Julianna Fajardo, DNP, FNP-BC | |
|
1355 Remington Rd, Schaumburg, IL 60173-4832 | |
| (630) 701-9009 | |
| Not Available |
| Full Name | Julianna Fajardo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1355 Remington Rd, Schaumburg, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154833648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 209015868 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Suburban Medical Center | Oak park, IL | Hospital |
| St Alexius Medical Center | Hoffman estates, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chicago Cardiology Institute Sc | 6103983176 | 17 |
News Archive
A study conducted by researchers at the University of Washington has highlighted the importance of serological testing for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Louisiana Tech University's College of Engineering and Science will host industry leaders from throughout the region as well as faculty and research experts from Louisiana Tech at the "Nanotechnology for Louisiana" conference, November 9 at the Louisiana Tech Shreveport Center in Shreveport.
Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought substantial public health benefits.
Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects.
› Verified 1 days ago
| Entity Name | Chicago Cardiology Institute Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568600286 PECOS PAC ID: 6103983176 Enrollment ID: O20090318000251 |
News Archive
A study conducted by researchers at the University of Washington has highlighted the importance of serological testing for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Louisiana Tech University's College of Engineering and Science will host industry leaders from throughout the region as well as faculty and research experts from Louisiana Tech at the "Nanotechnology for Louisiana" conference, November 9 at the Louisiana Tech Shreveport Center in Shreveport.
Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought substantial public health benefits.
Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julianna Fajardo, DNP, FNP-BC 1355 Remington Rd, Schaumburg, IL 60173-4832 Ph: () - | Julianna Fajardo, DNP, FNP-BC 1355 Remington Rd, Schaumburg, IL 60173-4832 Ph: (630) 701-9009 |
News Archive
A study conducted by researchers at the University of Washington has highlighted the importance of serological testing for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Louisiana Tech University's College of Engineering and Science will host industry leaders from throughout the region as well as faculty and research experts from Louisiana Tech at the "Nanotechnology for Louisiana" conference, November 9 at the Louisiana Tech Shreveport Center in Shreveport.
Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought substantial public health benefits.
Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects.
› Verified 1 days ago
Gay Bautista, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 921 N Plum Grove Rd, Schaumburg, IL 60173 Phone: 847-359-3400 Fax: 847-358-2770 | |
Ashley Melvin, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1901 N Roselle Rd, Schaumburg, IL 60195 Phone: 443-383-9300 | |
Lisa K Siby, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1355 Remington Rd, Suite H, Schaumburg, IL 60173 Phone: 630-701-9009 | |
Tejal B Patel, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1927 Farnham Ct, Schaumburg, IL 60194 Phone: 224-231-7746 | |
Shalom Adenekan, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 675 S Roselle Road, Schaumburg, IL 60193 Phone: 773-886-4771 | |
Nicole Turano, APN, ANP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 919 N Plum Grove Rd, Unit A, Schaumburg, IL 60173 Phone: 847-850-8185 Fax: 978-701-6065 | |
Mrs. Mary Mcmanus, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1855 W Irving Park Rd, Schaumburg, IL 60193 Phone: 866-389-2727 |